DZIP3 and central nervous system cancer: IHC was used to evaluate the correlation between DZIP3 expression and CD31 (a novel angiogenesis marker) [14]; DZIP3 mainly expressed on vascular endothelial cells and was negatively associated with CD31 at the protein level indicating that DZIP3 could affect the angiogenesis process of glioma (Figure 3A).